{"id":"W2944756121","doi":"10.1007/s40265-019-01115-y","title":"Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Pfizer","keywords":"Erlotinib; Medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Oncology; Pharmacology; Cancer; Erlotinib Hydrochloride; EGFR inhibitors; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001082777,0.0002152996,0.0008364461,0.00009801787,0.00002075859,0.000007301421,0.0001784361,0.00007900033,0.00008585629],"category_scores_gemma":[0.000001087538,0.0001252877,0.0002416139,0.0002628401,0.00001640397,0.00002117268,0.00003994866,0.0001810141,0.00003131159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002117567,"about_ca_system_score_gemma":0.0002652498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009169438,"about_ca_topic_score_gemma":0.000007658942,"domain_scores_codex":[0.9990003,0.00003485977,0.0003587087,0.0002479868,0.0001796388,0.0001785446],"domain_scores_gemma":[0.9992052,0.00006667808,0.0002130219,0.0004562582,0.00002814842,0.00003068002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00000754277,0.0001880149,0.00006695051,0.07255857,0.0006230897,0.00003451141,0.001168355,0.000006699127,1.757253e-7,0.0001454159,0.001311763,0.9238889],"study_design_scores_gemma":[0.001478429,0.00003694548,0.0001273226,0.02561936,0.005977525,0.000003224126,0.0006185129,0.000005492137,0.000001554737,0.000003513591,0.9660013,0.0001267995],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001859279,0.942575,0.000005034382,0.00009614036,0.0002337361,0.002802298,0.00007073616,0.000008114307,0.05402298],"genre_scores_gemma":[0.0002107752,0.9908789,0.0002996241,0.0001444785,0.00006144091,0.0008948428,0.000184075,0.00003325349,0.007292563],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9646896,"threshold_uncertainty_score":0.5109085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0261137380604118,"score_gpt":0.3865650029237402,"score_spread":0.3604512648633285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}